World Clinical Drug
|
2022, 43(6): 778-781
• Article •
A case study on thrombocytopenia induced by piperacillin sodium and tazobactam sodium after renal transplantation
Full
Mingming CHENG1, 2, Chenyang SHI1, Guorong FAN1, Hui PAN1, *
Affiliations
- 1.Department of Clinical Pharmacy, Shanghai General Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China
- 2.Department of Pharmacy, Shanghai Fourth People's Hospital Affiliated to Tongji University, Shanghai 200434, China
Published: 2022-06-10
doi: 10.13683/j.wph.2022.06.022
Outline
piperacillin sodium and tazobactam sodium
/
renal transplantation
/
thrombocytopenia
程明明, 石晨阳, 范国荣, 潘慧.
1例哌拉西林钠他唑巴坦钠致肾移植术后患者血小板减少的病例分析.
世界临床药物,
2022
, 43
(6)
: 778
-781
.
DOI: 10.13683/j.wph.2022.06.022
Mingming CHENG, Chenyang SHI, Guorong FAN, Hui PAN.
A case study on thrombocytopenia induced by piperacillin sodium and tazobactam sodium after renal transplantation[J].
World Clinical Drug,
2022
, 43
(6)
: 778
-781
.
DOI: 10.13683/j.wph.2022.06.022
Year 2022 volume 43 Issue 6
11
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.06.022
- Receive Date:2021-12-29
- Online Date:2026-11-19
- Published:2022-06-10